{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:31:29Z","timestamp":1760059889925,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Croatian Science Foundation","doi-asserted-by":"publisher","award":["UIP-2017-05-1965","IP-2022-10-2285"],"award-info":[{"award-number":["UIP-2017-05-1965","IP-2022-10-2285"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Patients with GG rs738409 patatin-like phospholipase domain-containing protein 3 (PNPLA3) genotype (148M variant) have greater risk to develop end-stage liver disease and its associated clinical complications, including hepatocellular carcinoma (HCC). We aimed to analyze the association between the PNPLA3 genotype and augmented inflammatory response in transplant candidates with end-stage alcoholic liver disease (ALD). Materials and Methods: Concentrations of 13 cytokines were measured in 106 end-stage ALD patients without HCC (40 with CC, 40 with CG, and 26 with GG genotype), 35 end-stage ALD patients with HCC, and 19 control patients by cytometric bead array. Results: We found significantly higher concentrations of IL-1, IFN-\u03b1, IFN-\u03b3, TNF-\u03b1, IL-6, CXCL8, IL-10, IL-12, IL-32, and IL-33 in patients with ALD compared to controls, while the concentration of CCL2 was significantly lower. No differences were observed in the concentration of IL-17 and IL-18. ALD patients with and without HCC had similar cytokine concentrations (p &gt; 0.05 for all comparisons). End-stage ALD patients without HCC of the GG genotype had significantly higher CCL2 concentrations (212.6 [135.9\u2013264.9] pg\/mL) compared to end-stage ALD patients without HCC carrying the CC\/CG genotypes (141.3 [104.1\u2013201.6] pg\/mL, p = 0.002, Mann\u2013Whitney). No significant differences across the genotypes were found for the remaining measured cytokines (p &gt; 0.05). GG carriers also had significantly higher levels of AST and ALT, and lower platelet counts. Conclusions: End-stage ALD patients without HCC who carry the PNPLA3 GG genotype have relatively higher CCL2 levels compared to those with the CC or CG genotypes. Relatively elevated CCL2 concentrations in GG patients might contribute to their increased risk of developing clinical complications compared to CC\/CG patients.<\/jats:p>","DOI":"10.3390\/medicina61071293","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:10:38Z","timestamp":1752833438000},"page":"1293","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-Risk PNPLA3 rs738409 Genotype Is Associated with Higher Concentrations of CCL2 in Liver Transplant Candidates with Alcoholic End-Stage Liver Disease"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-2572","authenticated-orcid":false,"given":"Ivan","family":"Budimir Bekan","sequence":"first","affiliation":[{"name":"Department of Surgery, Merkur University Hospital, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"\u0160isl","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Immunology, Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Physiology and Immunology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7523-1047","authenticated-orcid":false,"given":"Alan","family":"\u0160u\u0107ur","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Immunology, Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Physiology and Immunology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0219-1800","authenticated-orcid":false,"given":"Ana","family":"Bainrauch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Merkur University Hospital, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerija","family":"Brali\u0107 Lang","sequence":"additional","affiliation":[{"name":"Private Family Physician Office Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Family Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavao","family":"Planini\u0107","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Kova\u010di\u0107","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Immunology, Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Anatomy, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2365-8249","authenticated-orcid":false,"given":"Danka","family":"Gr\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Immunology, Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Physiology and Immunology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6270-2305","authenticated-orcid":false,"given":"Anna","family":"Mrzljak","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomislav","family":"Kelava","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Immunology, Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Physiology and Immunology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"ref_1","unstructured":"GBD 2019 Risk Factors Collaborators (2020). Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1223\u20131249."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3748\/wjg.v24.i26.2785","article-title":"Liver transplantation and alcoholic liver disease: History, controversies, and considerations","volume":"24","author":"Marroni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3748\/wjg.v26.i12.1273","article-title":"Importance of genetic polymorphisms in liver transplantation outcomes","volume":"26","author":"Kelava","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bainrauch, A., \u0160isl, D., Markoti\u0107, A., Ostoji\u0107, A., Ga\u0161parov, S., Lang, V.B., Kova\u010di\u0107, N., Gr\u010devi\u0107, D., Mrzljak, A., and Kelava, T. (2021). NOTCH3 rs1043996 Polymorphism Is Associated with the Occurrence of Alcoholic Liver Cirrhosis Independently of PNPLA3 and TM6SF2 Polymorphisms. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194621"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2011.02534.x","article-title":"PNPLA3 rs738409C\/G polymorphism in cirrhosis: Relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence","volume":"31","author":"Falleti","year":"2011","journal-title":"Liver Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.cgh.2024.04.006","article-title":"PNPLA3, obesity and heavy alcohol use in cirrhosis patients may exert a synergistic increase hepatocellular carcinoma risk","volume":"22","author":"Thrift","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2234221","DOI":"10.1001\/jamanetworkopen.2022.34221","article-title":"Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e31987","DOI":"10.5812\/hepatmon.31987","article-title":"A Meta-Analysis of the Association Between the I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene and the Presence of Chronic Hepatitis C","volume":"15","author":"Zhang","year":"2015","journal-title":"Hepat. Mon."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/jgh.12540","article-title":"PNPLA3 in end-stage liver disease: Alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival","volume":"29","author":"Friedrich","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.dld.2021.06.015","article-title":"PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center","volume":"54","author":"Balcar","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mitsche, M.A., Hobbs, H.H., and Cohen, J.C. (2018). Patatin-like phospholipase domain-containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. J. Biol. Chem., 293.","DOI":"10.1074\/jbc.AAC118.004058"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1194\/jlr.M046607","article-title":"PNPLA3 mediates hepatocyte triacylglycerol remodeling","volume":"55","author":"Ruhanen","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3945\/jn.115.210633","article-title":"PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity","volume":"145","author":"Mondul","year":"2015","journal-title":"J. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Salari, N., Darvishi, N., Mansouri, K., Ghasemi, H., Hosseinian-Far, M., Darvishi, F., and Mohammadi, M. (2021). Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: A systematic review and meta-analysis. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00789-4"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jcmm.14839","article-title":"PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells","volume":"24","author":"Yuan","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/13816128113199990587","article-title":"Clinical aspects of tumor necrosis factor-\u03b1 signaling in hepatocellular carcinoma","volume":"20","author":"Jang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nenu, I., Toadere, T.M., Topor, I., \u021aichindeleanu, A., Bondor, D.A., Trella, \u0218.E., Sparchez, Z., and Filip, G.A. (2023). Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102623"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1746.2011.07003.x","article-title":"Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease","volume":"27","author":"Gao","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1111\/jcmm.14930","article-title":"LPS-induced inflammation desensitizes hepatocytes to Fas-induced apoptosis through Stat3 activation-The effect can be reversed by ruxolitinib","volume":"24","author":"Markotic","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2249.2012.04609.x","article-title":"Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates","volume":"169","author":"Lemmers","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1158\/1535-7163.MCT-16-0124","article-title":"Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model","volume":"16","author":"Teng","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_23","first-page":"21","article-title":"CCL2\/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway","volume":"39","author":"Zhuang","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/08820538.2020.1755320","article-title":"Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients","volume":"35","author":"Cvitkovic","year":"2020","journal-title":"Semin. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.ijo.0802839","article-title":"Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects","volume":"29","author":"Christiansen","year":"2005","journal-title":"Int. J. Obes."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1210\/jc.2004-1696","article-title":"Monocyte chemoattractant protein-1 release is higher in visceral than subcu-taneous human adipose tissue (AT): Implication of macrophages resident in the AT","volume":"90","author":"Bruun","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bauer, A., and Rawa, T. (2024). Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021333"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000527784","article-title":"Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease","volume":"41","author":"Okano","year":"2023","journal-title":"Dig. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2021.05.041","article-title":"Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis","volume":"75","author":"Saleh","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hep4.1483","article-title":"Primary Alcohol-Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene-Expression Profiles","volume":"4","author":"Liu","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcmgh.2018.10.007","article-title":"The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers","volume":"7","author":"Bartneck","year":"2019","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signaling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"ref_34","first-page":"e131","article-title":"Pharmacological targeting of the CCL2\/CCR2 axis for atheroprotection: A meta-analysis of preclinical studies","volume":"42","author":"Asare","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fei, L., Ren, X., Yu, H., and Zhan, Y. (2021). Targeting the CCL2\/CCR2 axis in cancer immunotherapy: One stone, three birds?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.771210"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/ceh.2018.78122","article-title":"Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: A systematic review and meta-analysis","volume":"4","author":"Shakiba","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5114\/ceh.2019.84780","article-title":"A systematic review and meta-analysis of evaluation of serum interleukin 8 levels in hepatocellular carcinoma","volume":"5","author":"Shakiba","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.imbio.2008.11.007","article-title":"Mechanisms of interleukin-1beta release","volume":"214","author":"Eder","year":"2009","journal-title":"Immunobiology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e39720","DOI":"10.7554\/eLife.39720","article-title":"Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells","volume":"7","author":"Plesch","year":"2018","journal-title":"Elife"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.aohep.2020.08.065","article-title":"PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population","volume":"20","author":"Peregud","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Lazarus","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e0306","DOI":"10.1097\/HC9.0000000000000306","article-title":"Altered profiles of circulating cytokines in chronic liver diseases (NAFLD\/HCC): Impact of the PNPLA3I148M risk allele","volume":"7","author":"Kirchmeyer","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kelava, T., Bekan, I.B., \u0160isl, D., \u0160ucur, A., Bainrauch, A., Bralic-Lang, V., Planini\u0107, P., Kovac\u00e8ic, N., Grc\u00e8evic, D., and Sesa, V. (2025, January 7\u201310). SAT-514 High-risk PNPLA3 rs738409 genotype is associated with higher CCL2 concentrations in liver transplant candidates with alcohol-related liver disease. Proceedings of the EASL Congress 2025, Amsterdam, The Netherlands.","DOI":"10.1016\/S0168-8278(25)00552-5"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1293\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:11:51Z","timestamp":1760033511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071293"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071293","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}